Tamarack Advisers’s Humana HUM Stock Holding History

Tamarack Advisers’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,000	Closed	-$9.28M	–	49
2021 Q4	$9.28M	Buy	+20,000	New	+$8.85M	3.81%	10

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tamarack Advisers's HUM Position: Q1 2022 in Review

Tamarack Advisers sold out of Humana (HUM) in Q1 2022, closing a stake of 20,000 shares — an estimated $9.28M sold.

Tamarack Advisers first reported a position in HUM in Q4 2021 and held it in 1 quarter. The position peaked at $9.28M in Q4 2021. 914 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

Tamarack Advisers reported no remaining Humana position as of Q1 2022 after selling out during the quarter.
Tamarack Advisers sold 20,000 Humana shares in Q1 2022, an estimated $9.28M.
Tamarack Advisers first reported a position in Humana in Q4 2021 and held it in 1 quarter.
Tamarack Advisers's Humana position peaked at $9.28M in Q4 2021.
914 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on Tamarack Advisers's 13F filing for Q1 2022, filed 11 May 2022.